(Q44927729)

7 December 2017

title

Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis (English)

1 reference

7 December 2017

Albert J Czaja

1

1 reference

7 December 2017

Herschel A Carpenter

series ordinal

2

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

39

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

1631-1638

1 reference

Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone

7 December 2017

cites work

1 reference

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Liver biopsy size matters in chronic hepatitis: bigger is better

21 January 2018

1 reference

Diagnosis and treatment of autoimmune hepatitis

21 January 2018

1 reference

7 January 2021

Treatment of autoimmune hepatitis

1 reference

7 January 2021

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

7 January 2021

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

1 reference

7 January 2021

Treatment strategies in autoimmune hepatitis

1 reference

7 January 2021

Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis

1 reference

7 January 2021

Azathioprine for long-term maintenance of remission in autoimmune hepatitis

1 reference

7 January 2021

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

7 January 2021

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

7 January 2021

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

1 reference

7 January 2021

Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis

1 reference

7 January 2021

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

1 reference

7 January 2021

Effects of meals and interruption of enterohepatic circulation on flow, lipid composition, and cholesterol saturation of bile in man after cholecystectomy

1 reference

7 January 2021

Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C.

1 reference

7 January 2021

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond

1 reference

7 January 2021

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

7 January 2021

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

7 January 2021

Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

1 reference

7 January 2021

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

7 January 2021

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

1 reference

7 January 2021

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Is liver fibrosis reversible?

1 reference

7 January 2021

Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis

1 reference

7 January 2021

Reversibility of hepatic fibrosis in autoimmune hepatitis

1 reference

7 January 2021

Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy

1 reference

7 January 2021

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

1 reference

7 January 2021

Regulation of cytokine and cytokine receptor expression by glucocorticoids

1 reference

7 January 2021

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

7 January 2021

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

1 reference

7 January 2021

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

1 reference

7 January 2021

Identification of a glucocorticoid response element in the human transforming growth factor beta 1 gene promoter

1 reference

7 January 2021

Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis

1 reference

7 January 2021

Understanding the pathogenesis of autoimmune hepatitis

1 reference

7 January 2021

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis

1 reference

7 January 2021

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

7 January 2021

Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20235

1 reference

7 December 2017

1 reference